Skip to main content
Log in

Comparion of serum angiotensin-converting enzyme in Graves' disease, toxic nodular goiter, and other thyroid conditions

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

Angiotensin-converting enzyme (ACE) was measured in plasma of patients with Graves' disease and with toxic nodular goiter, as well as in their treated counterparts and in normal controls. A significant elevation of ACE levels and a positive correlation between ACE, thyroxine, and triiodothyronine levels was found in both groups of thyrotoxicosis. Parallel fluctuations of triiodothyronine and ACE levels, albeit with a certain lag of the latter, was observed in patients in whom multiple measurements were taken. ACE levels, which were also determined in hypothyroid patients and in patients with euthyroid goiter on suppression therapy, were in the same range as normal controls and as in treated thyrotoxic patients. We conclude that the pathogenesis of thyrotoxicosis does not play a role in ACE elevation but that increased thyroid hormone seems to induce elevation of ACE. ACE elevation in thyrotoxicosis may constitute an integral part of the reninangiotensin axis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ACE:

Angiotensin-converting enzyme

n.g.:

Nodular goiter

T4 :

Thyroxine

T3 :

Triiodothyronine

References

  1. Bakiri F, Benmiloud M, Vallotton MB (1983) The reninangiotensin system in panhypopituitarism: dynamic studies and therapeutic effects in Sheehan's syndrome. J Clin Endocrinol Metab 56:1042–1047

    Google Scholar 

  2. Bouhnik J, Galen F-X, Clauser E, Menard J, Corvol P (1981) The renin-angiotensin system in thyroidectomized rats. Endocrinology 108:647–650

    Google Scholar 

  3. Gavras H, Brunner HR, Turini GA, Kershaw GR, Tifft CP, Cuttelod S, Gavras I, Vukovich RA, McKinstry DN (1978) Antihypertensive effect of the oral angiotensin-converting enzyme inhibitor Sq 14225 in man. N Engl J Med 298:991–995

    Google Scholar 

  4. Hauger-Klevene JH, Brown H, Zavaleta J (1972) Plasma renin activity in hyper- and hypothyroidism: effect of adrenergic blocking agents. J Clin Endocrinol Metab 34:625–629

    Google Scholar 

  5. Jimenez E, Montiel M, Narvaez JA, Morell M (1982) Effects of hyper- and hypothyroidism on the basal levels of angiotensin I and kinetic parameters of renin-angiotensin system in male rats. Revista Esp de Fisiol 38:149–153

    Google Scholar 

  6. Laragh JH, Sealey JE (1981) The renin-aldosterone axis for blood pressure, electrolyte homeostasis, and diagnosis of high blood pressure. In: Williams RH (ed) Textbook of Endocrinology. WB Saunders, Philadelphia pp 1064–1079

    Google Scholar 

  7. Laragh JH, Soffer RL, Case DB (1978) Converting enzyme, angiotensin II and hypertensive disease. Am J of Med 64:147–160

    Google Scholar 

  8. Lieberman J (1975) Elevation of serum angiotensin-converting enzyme level in sarcoidosis. Am J Med 59:365–372

    Google Scholar 

  9. Nakamaru M, Ogihara T, Higaki J, Kumahara Y, Murakami K, Kuma K (1983) Plasma inactive renin in patients with hyperthyroidism. J Clin Endocrinol Metab 56:198–201

    Google Scholar 

  10. Nakamura Y, Takeda T, Ishii M, Nishiyama K, Yamakada M, Hirata Y, Kimura K, Murao S (1982) Elevation of serum angiotensin-converting enzyme activity in patients with hyperthyroidism. J Clin Endocrinol Metab 55:931–934

    Google Scholar 

  11. Silverstein E, Schussler GC, Friedland J (1983) Elevated serum angiotensin-converting enzyme in hyperthyroidism. Am J Med 75:233–236

    Google Scholar 

  12. Smyth PPA, Neylan D, O'Donovan DK (1982) The prevalence of thyroid-stimulating antibodies in goitrous disease assessed by cytochemical section bioassay. J Clin Endocrinol Metab 54:357–361

    Google Scholar 

  13. Smallridge RC, Rogers J, Verma PS (1983) Serum angiotensin-converting enzyme: alterations in hyperthyroidism, hypothyroidism, and subacute thyroiditis. JAMA 250:2489–2493

    Google Scholar 

  14. Sütterlin U, Gless K-H, Schaz K, Hüfner M, Schütz V, Hunstein W Periphere Effekte von Schilddrüsenhormonen: Änderung der intrazellulären Na-Konzentration, des Strophantin-sensitiven Na-Transports und des Na-Li Countertransports in Erythrozyten. Klin Wochenschr (in press)

  15. Taylor JT, Freeman S (1980) Spectrophotometry of angiotensin-converting enzyme in sarcoidosis. Clin Chem 26:1756

    Google Scholar 

  16. Wessels F, Junge-Hülsing G, Losse H (1976) Untersuchungen zur Natriumpermeabilität der Erythrozyten bei Hypertonikern und Normotonikern mit familiärer Hochdruckbelastung. Z Kreislaufforschg 56:374–380

    Google Scholar 

  17. Yotsumoto H, Imai Y, Kuzuya N, Uchimura H, Matsuzaki F (1982) Increased levels of serum angiotensin-converting enzyme activity in hyperthyroidism. Ann Intern Med 96:326–328

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Czernobilsky, H., Fiehn, W. & Ziegler, R. Comparion of serum angiotensin-converting enzyme in Graves' disease, toxic nodular goiter, and other thyroid conditions. Klin Wochenschr 63, 518–522 (1985). https://doi.org/10.1007/BF01747982

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01747982

Key words

Navigation